| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUUCGCCUCACAAACAACCACAGAACCACAAGUGCGGUGCAAACUUUCU… | 5474 nt | 0.4355 | |
| AUUCGCCUCACAAACAACCACAGAACCACAAGUGCGGUGCAAACUUUCU… | 5540 nt | 0.4368 | |
| AAACACACCCCCGCGCCCGUUCGCAGCUGCCACCCCGGGUGUUCCAAAG… | 5537 nt | 0.4459 | |
| AAACACACCCCCGCGCCCGUUCGCAGCUGCCACCCCGGGUGUUCCAAAG… | 5603 nt | 0.4471 |
This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
A study in mice demonstrated that plasma exosomes isolated on day 1 post-traumatic brain injury (TBI) and fracture (TF1) significantly promoted osteoblast proliferation and enhanced mRNA and protein expression of the osteogenic marker RUNX2 in MC3T3-E1 cells [Yang et al. DOI:10.1016/j.jot.2021.09.003].